MedTrace Logo

Use of Stem Cells Cultured on a Scaffold for the Treatment of Aneurysmal Bone Cysts (ABC)

NCT03066245 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2019-07-24

No results posted yet for this study

Summary

Patients qualified for this study are those diagnosed with ABCs and failed to be treated with other forms of classical therapies. In which, these patients will be engrafted with biodegradable scaffolds seeded with Mesenchymal Stem Cells (MSCs) supplemented with Platelet lysate.

Conditions

  • Aneurysmal Bone Cyst

Interventions

BIOLOGICAL

MSC-PLGA

Bone marrow derived MSC seeded on biodegradable PLGA, supplemented with PL.

Sponsors & Collaborators

  • Sophia Al-Adwan

    lead OTHER

Principal Investigators

  • Abdalla Awidi · University of Jordan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
28 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-03
Primary Completion
2019-12-31
Completion
2020-03-31

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03066245 on ClinicalTrials.gov